Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion type Assertion NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_head.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion description "[The detection of a wide distribution of bombesin/GRP receptors in human prostate carcinomas supports the view that they may be involved in modulation of tumor progression and suggests that approaches based on binding of bombesin receptor antagonists or new targeted cytotoxic bombesin analogs to prostate cancers could be considered for the therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion evidence source_evidence_literature NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion SIO_000772 10679759 NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion wasDerivedFrom befree-2016 NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.
- NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_assertion wasGeneratedBy ECO_0000203 NP275430.RAIm2-KZ16mKphuEZIH1bX3zT8gN9RqzTd-FVLtUqrdzA130_provenance.